Electronic Trial Master File Systems Market Trends : Latest Innovations, Drivers and Industry Key Events 2018 – 2025

 

Global Electronic Trial Master File (eTMF) Systems Market: By Component (Software, Services), Deployment Mode (Cloud/Web-Based, On-Premise), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others), Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast to 2025
Market Highlights
According to MRFR analysis, Global Electronic Trial Master File Systems Market Trends is expected to register a CAGR of 13.11% during the forecast period of 2019 to 2025 and anticipated to reach USD 1,825 Million by 2025.
The eTMF serves as a central repository to store and manage essential clinical trial documents and content for possible use in regulatory submissions. The eTMF software streamlines agency compliance with standards-based exports, and eSubmissions enables sharing between clinical trial stakeholders with language-independent taxonomy.
The growth of the global eTMF systems market is fueled by several factors such as rising activities in terms of acquisitions, new solution and service deployments, and collaborations by key players operating in the market, coupled with the increasing number of clinical trial studies. For instance, in October 2019, SureClinical Inc. launched a transparent eTMF pricing policy. To provide value to the prospective users, the company has posted its prices and terms online to battle price discrimination in this industry. However, budget constraints of the small and medium-sized enterprises, along with the dearth of skilled professionals for operating the electronic systems, can hinder the preference of such solutions. As a result, such elements can hamper the growth of the market during the forecast period.
Several market players currently dominate the global eTMF systems market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in June 2018, Phlexglobal, a UK-based specialist provider of TMF and eTMF management solutions, is adopting Version 1 of the eTMF Exchange Mechanism Standard (eTMF-EMS) of the TMF Reference Model (TMF-RM) into PhlexEview, the company’s eTMF technology. Such strategies push the growth of the eTMF systems market.
Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/8772
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada. The eTMF systems market in the Americas has been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European eTMF systems market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The eTMF systems market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The eTMF systems market in this region is anticipated to be the fastest-growing during the assessment period due to the increased adoption rate of eTMF software and services in the Asian countries. The eTMF systems market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The Global eTMF Systems Market has been segmented based on Component, Deployment Mode, and End User.
The global eTMF systems market has been segmented, based on the component, into software and services. The software segment is expected to hold the majority share of the market owing to the increasing number of solution launches by the prominent players in recent years. The services segment is expected to be the fastest-growing due to the increasing uptake of eTMF services by pharmaceutical and life science companies.
The global eTMF systems market, based on deployment model, has been segmented into cloud/web-based, and on-premise. The cloud/web-based segment holds the maximum share owing to the technological advancements in cloud-based solutions in recent years.
The end-users of the market are pharmaceutical and biotechnology companies, contract research organizations, and others. The increasing number of clinical trials conducted by pharma firms is leading to the market size of the pharmaceutical and biotechnology companies’ segment.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/etmf-systems-market-8772
Key Players
Some of the Key Players in the Global eTMF Systems Market are Aurea, Inc. (US), Covance Inc. (US), ePharmaSolutions (US), MasterControl, Inc. (US), Oracle (US), Phlexglobal (UK), SureClinical Inc. (US), TransPerfect (US), Veeva Systems (US), and Wingspan (IQVIA) (US).
Related Report: Laparoscopy Devices Market Research Report - Global Forecast till 2023 - https://www.marketresearchfuture.com/infographics/laparoscopy-device-market 
NOTE: Our Team of Researchers are Studying COVID-19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering COVID-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Hemorrhoid Treatment Devices Market Size : Industry Growth Factors, Applications, Growth Analysis, Key Players and Forecasts by 2025

 

Global Hemorrhoid Treatment Devices Market: Information by Device Type (Rubber Band Ligators, Infrared Coagulators, Proctoscopes, Anoscopes, Doppler probes, Cryotherapy Devices, bipolar Probes, Others), Procedure (Rubber Band Ligation, Sclerotherapy, Infrared Coagulation, Others), End-User (Hospitals & Clinics, Ambulatory Surgery Centers and others) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Forecast till 2025
According to Market Research Future (MRFR), the global Hemorrhoid Treatment Devices Market Size is projected to register a CAGR of 5.5 % from 2018 to 2023 (forecast period).
Among the most uncomfortable disorders a patient may have is hemorrhoids, and most people under the age of fifty do not know what hemorrhoids are. The general population ignores the disorder until they are affected by the disorder and begin to experience symptoms such as discomfort and itching associated with the disorder. As per the American Society of Colon & Rectal Surgeons, hemorrhoids are one of the most common disorders, and more than half of the population may develop hemorrhoids after the age of 30. The prevalence of hemorrhoids (also known as piles) in the United States is estimated to be 4.4%, with the majority of cases occurring between the ages of 45 and 65, similarly among men and women. But just one-third of these individuals are seeking medical care, such as surgery, medications, etc., with most opting for over-the-counter relief obtained from pharmacies.
There are two types of hemorrhoids (piles), internal and external, which vary in their location. While there is no specific cause of hemorrhoids, there are a number of causes that may lead to the disorder: age, chronic constipation or diarrhea, pregnancy, heredity, discomfort during bowel movements, impaired bowel function. Some patients do not even experience symptoms, but those that do experience bleeding during bowel movements, protrusion during bowel movements and itching, discomfort, and sensitive lumps in the anal region. There are a range of options for home care, such as sitz baths, wipes, creams, fiber supplements suppositories, and hemorrhoid pillows.
Request For Free Sample Copy : https://www.marketresearchfuture.com/sample_request/8726
Market Dynamics
Increased cases of intra-abdominal pressure due to improper dietary eating, obesity, and pregnancy are factors that increase the market size of hemorrhoid treatment. Changes in lifestyle, including increasing consumption of alcohol and fat-induced foods, have a positive effect on the market growth of hemorrhoid treatment. However, inadequate knowledge and preparedness for medical treatment due to a feeling of embarrassment hinders the growth of the market.
Segmentation
The global market for hemorrhoids treatment is segmented based on treatment type, route of administration, and distribution channel.
Based on treatment type, the market for hemorrhoids treatment is segmented into non-surgical and surgical procedures. The non-surgical is further sub-segmented into, NSAIDs, laxatives, and herbals. The surgical procedures further sub-segmented into band litigation, cryotherapy, sclerotherapy.
Based on the route of administration, the market is segmented into oral and topical agents.
The distribution channel is segmented into retail pharmacies, online pharmacies, hospital pharmacies, and others.
Access Report Details @ https://www.marketresearchfuture.com/reports/hemorrhoid-treatment-devices-market-8726
Regional Analysis
The global hemorrhoids treatment market is segmented into four global regions, namely- the Americas, Europe, the Asia Pacific, and the Middle East & Africa.
Hemorrhoids will impact more than half of the U.S. population in their lifetimes. Hemorrhoids are swollen, inflamed veins in the anal canal, which can cause extreme discomfort in the form of pain and itching. At present, patients suffering from hemorrhoids who seek relief from their pain can choose from a range of products with varying positive and negative effects. Specific products, such as creams, wipes, suppositories, and pads, are useful in offering immediate relief, but cannot be used for permanent care. Hemorrhoid cushions can be used, but they are noticeable and can be uncomfortable with extended use. Furthermore, according to Home Care Magazine, 24 million baby boomers had reached the age of 50 in 2014. Those over the age of 65 will tend to represent a greater proportion of the total population. By 2020, more than 54 million residents in the United States will be over 65 years of age. In addition, by 2030, members of the 66 to 84 age group will make up an estimated 20% of the U.S. population.
Europe registered for the second-largest market behind the Americas. Europe is comprised of two parts, namely Western Europe and Eastern Europe. Western Europe has a significant market share, primarily contributed by Germany, the United Kingdom, and France. Primary factors that are responsible for the growth of the hemorrhoid treatment market include a sedentary lifestyle, lack of physical activity, alcoholism, obesity, low dietary fiber intake, etc. in most regions of Europe. Lack of understanding and preparedness for medical care due to a sense of shame hinders the growth of the market.
The Asia Pacific is the fastest-growing region on the market for hemorrhoids. Growing need for better diagnostic devices, better and safer therapeutic methods, rapidly evolving technology, and the presence of a vast patient pool are driving the growth of this market in the Asia Pacific region.
Key Players
Some of the major participants in the global hemorrhoids treatment market are AstraZeneca plc, Abbott Laboratories, AstraZeneca plc, Bayer AG, GlaxoSmithKline, Boehringer Ingelheim GmbH, Cook Medical, Boston Scientific Corporation, CONMED Corporation, Pfizer Inc., Takeda Pharmaceutical Company, Taro pharmaceuticals Inc., Astra Zeneca, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals, Olympus Corporation, and others.
Related Report:Medical Implants Market Research Report - Global Forecast till 2023 - https://www.marketresearchfuture.com/infographics/medical-implants-market 
NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

 

Cholesterol Testing Services Market Size, Share, Growing Growth Opportunities, Driving Factors With Top Players 2025

 

Global Cholesterol Test Market Research Report: Information by Product Type (Test Kits and Test Strips), Test Type (Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol and Triglycerides/VLDL Cholesterol Test), Distribution Channel (Over the Counter and Prescription Based), End-User (Hospitals & Clinics, Homecare, Diagnostic Centers and others) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) – Forecast till 2025

Market Highlights

According to MRFR analysis, the Cholesterol Testing Services Market is expected to register a CAGR of 7.4% during the forecast period of 2019 to 2025 and is expected to reach USD 2,465 Million by 2025. The growth of the global cholesterol test market is driven by various factors such as the increasing prevalence of cardiovascular diseases & obesity, government initiatives to improve the quality of clinical diagnostics. However, the lack of a skilled workforce is projected to hamper the growth of the global cholesterol test market. According to recent studies, cardiovascular disease is the leading global cause of death, accounting for more than 17.6 million deaths per year in 2016, a number that is expected to grow to more than 23.6 million by 2030. The increasing incidences of obesity are driving the growth of the cholesterol test market. For instance, in 2016, 39% of adults aged 18 years and over (39% of men and 40% of women) were overweight. Globally, about 13% of the world’s adult population was obese in 2016. The worldwide prevalence of obesity nearly tripled between 1975 and 2016,

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/8738

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The cholesterol test market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. As per recent studies, most (55.4%) of the Canadian adult population categorized as overweight (34.2%) or obese (21.2%). Furthermore, the prevalence of obese classes I, II, and III will increase to 14.8%, 4.4% and 2.0%, respectively. The European cholesterol test market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

According to WHO, the obesity rate in Germany is 23.7% which means that Germany has one of the highest obesity rates in Europe, but is still behind the UK, which has a rate of 26.2 %. The cholesterol test market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

Due to the increasing prevalence of cardiovascular diseases and obesity, the market in Asia-Pacific is expected to be the fastest-growing. According to WHO, Obesity in China is a major health concern with overall rates of obesity between 5% and 6% for the country, but greater than 20% in some cities where fast food is popular. The cholesterol test market in the Middle East & Africa has been divided into the Middle East and Africa.

Browse Complete Toc :
https://www.marketresearchfuture.com/reports/cholesterol-test-market-8738

Segmentation

The Global Cholesterol Test Market has been segmented based on Product Type, Test Type, Distribution Channel, and End User. The market, based on product type, has been divided into test kits and test strips. The test kits segment is likely to be the largest segment during the review period due to the growing awareness and adoption of preventive healthcare. The market, based on test type, has been divided into total cholesterol test, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides/VLDL cholesterol test. The total cholesterol test segment is likely to be the largest segment during the review period due to the growing importance of the test.

A complete cholesterol test includes the calculation of four types of fats (lipids) in blood. The market, based on distribution channel, has been divided into over the counter and prescription-based. The prescription-based segment is likely to be the largest segment during the review period. The global cholesterol test market has been segmented, based on end user, into hospitals & clinics, homecare, diagnostic centers, and others. The hospitals & clinics segment is expected to hold the majority share of the market owing to the rising in visits of patients in the hospitals and clinics.

Key Players Some of the Key Players in the Global Cholesterol Test Market are Quest Diagnostics Incorporated, Cell Biolabs, Inc., Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Thermo Fisher Scientific, PTS DIAGNOSTICS, Alere Inc., F. Hoffmann-La Roche AG, and Eurofins Scientific.

 

Related Report: Meningitis Diagnosis and Treatment Market Research Report - Global Forecast till 2023 - https://www.marketresearchfuture.com/infographics/meningitis-diagnosis-and-treatment-market 

 

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Asthma Inhaler Device Market: Business Opportunities, Competition & Key Companies, Current Trends and Challenges 2025

Asthma Inhaler Device Market: Information by Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Mode of Operation (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), End User (Hospitals & Clinics, Homecare, Others) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Forecast till 2025

Market Highlights

Asthma Inhaler Device Market is expected to register a CAGR of 6.42% during the forecast period with a market value of USD 19,677.54 Million till 2025. Inhaler devices have been proved to be the safest and most effective way to treat and control asthma and other respiratory diseases, as the inhaled medication reaches the lungs directly.

Segment Analysis

The Global Asthma Inhaler Device Market has been segmented by Type, Mode of Operation, and End User.

The market, based on type, has been bifurcated into the metered dose inhaler, dry powder inhaler, and soft mist inhaler. The metered-dose inhaler is further sub segmented into standard pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers, and metered-dose inhaler with a spacer.

Based on the mode of operation, the asthma inhaler device market has been segregated into manually operated inhaler devices and digitally operated inhaler devices.

The global asthma inhaler device market, based on end user, has been segmented into hospitals & clinics, home care, and others.

Browse Complete Toc :
https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market-1653

Regional Analysis

The Global Asthma Inhaler Device Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas are likely to hold the largest share of the global asthma inhaler device market during the assessment period. The increase in the incidence of asthma, rising demand for metered dose inhalers, adoption of smart inhalers by the population, and increasing demand for advanced technologies is expected to drive the market growth in the American region.

The Europe market established substantial growth in the market due to the presence of major players such as GlaxoSmithKline PLC, AstraZeneca, and Boehringer Ingelheim, the rising adoption of respiratory inhalers by hospitals and patients in European countries and continuous efforts made by the European Academy of Allergy & Clinical Immunology to increase awareness about asthma.

Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of rapidly developing economies such as China, India, and South Korea and the high prevalence of asthma.

The asthma inhaler device market in the Middle East & Africa is expected to witness gradual growth owing to increasing cases of asthma and demand for better treatments in the Middle Eastern countries.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/1653

Market Players

MRFR recognizes the following companies as the key players in the Global Asthma Inhaler Device Market GlaxoSmithKline plc (UK), Koninklijke Philips NV (Netherlands), AstraZeneca (UK), Cipla Inc. (India), Boehringer Ingelheim International GmbH (Germany), Beximco Pharmaceuticals Ltd (Bangladesh), Merck & Co., Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Chiesi Farmaceutici SpA (Italy), and Medisol Lifescience Pvt. Ltd (India).

Key Findings of the Study

• The Global Asthma Inhaler Device Market is estimated to grow at USD 19,677.54 Million by 2025 at a CAGR of 6.42% during the assessment period
• Americas accounted for the largest share of the global asthma inhaler device market due to the increasing incidence rate of asthma
• Based on type, the metered dose inhalers segment accounted for the largest market share of 42.6% in 2018
• Based on the mode of operation, the manually operated inhaler device segment accounted for the largest market share of 68.1% in 2018
• On the basis of end-user, the hospitals & clinics segment accounted for the largest market share of 52.8% in 2018

Related Report: Montelukast API Market Research Report - Global Forecast till 2023 - https://www.marketresearchfuture.com/infographics/montelukast-api-market 

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid-19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Platelet Agitator Market: Market Segments, Dynamics, Size, Supply & Demand, Current Trends and Forecast 2027

Platelet Agitator Market Research Report: Information by Type (Flatbed, Circular and Combination devices), Capacity (Small, Medium and Large), End User (Autonomous Blood Banks, Hospital-Based Blood Banks and others) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) – Forecast till 2027

Market Synopsis:

The strong value maintained by the biomedical industry is likely to proliferate the Platelet Agitator Market over the next couple of years. A rise in the research & development activities coupled with increased investments is likely to favor the growth of the global platelet agitator market. Platelet agitators offer safe and reliable storage of platelets under controlled environments to and large volume data. This is likely to increase its adoption in the healthcare industry through the review period. Additionally, the boom witnessed in the healthcare sector coupled with rising healthcare expenditure is expected to encourage platelet agitator market growth and expansion.

Market Segmentation:

By type, the global platelet agitator market has been segmented into flatbed, circular, and combination devices. The flatbed segment is further sub-segmented into horizontal and vertical agitator. The flatbed agitator currently holds a dominant share of the market which accounts for 64.9% share. It is likely to exhibit immense growth over the next couple of years.

By capacity, the platelet agitator market is segmented into small, medium, and large. The medium segment held the most significant share in 2015 and is expected to retain its prominence towards the end of the forecast period.

By end-user, the global platelet agitator market has been segmented into autonomous blood banks, hospital based blood banks, and others.

Request For Free Sample Copy :
https://www.marketresearchfuture.com/sample_request/1803 

Regional Analysis:

By region, the global platelet agitator market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America currently holds the maximum share in the global market accounting for 36.6% share. It is likely to retain its pole position throughout the assessment period. The regional market is estimated to reach a valuation of USD 170.2 Mn by the end of the forecast period. The growth in the region is attributable to the consolidation of key market players, technological advancements, rising healthcare expenditure, increasing patient pool, developed healthcare sector, etc.

Europe is one of the most significant growth pockets in the global platelet agitator market. It is likely to secure the second position globally over the assessment period. Asia Pacific exhibit tremendous potential for growth. It is set to register a relatively higher CAGR of 4.6% during the projection period. One of the key factors driving the growth of the market in the region is the increased investments for research & development in biomedical industry, especially in countries such as China, South Korea, India, Japan, etc.

Competitive Dashboard:

Some of the key players profiled by MRFR in the report are Fanem Ltda., Helmer Scientific, TERUMO PENPOL PVT LIMITED, KW apparecchi scientifici, LABCOLD, Meditech Technologies India Private Limited, Boekel Scientific, EMSAS Electrical Equipment Industry & Trading Inc., Nuve, SARSTEDT AG & Co., and Zhejiang Sujing Purification Equipment Co.Ltd.

Industry Developments:

In January 2018, U.S. Food and Drug Administration (FDA) and the Department of Defense’s (DoD) Office of Health Affairs launched a joint program which includes providing extensive manufacturing and clinical advice for prioritized products. Presently, high priority products include freeze-dried plasma, cold-stored platelets, and cryopreserved platelets.

Related Report: Montelukast Intermediate Market Global Research Report - Forecast till 2023- https://www.marketresearchfuture.com/infographics/montelukast-intermediate-market  

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Dental Radiology And Dental Imaging Devices Market Size – Rising New Technologies Research Forecast to 2023

Dental Radiology and Dental Imaging Devices Market Research Report: Information by Method (Intraoral, Extraoral and others), Devices (Dental Radiology Devices and Dental Imaging Devices), Application (Diagnosis, Therapeutic, Cosmetic and Forensic), Imaging Types (2D Imaging and 3D Imaging), End User (Hospitals & Dental Clinics, Forensic Laboratories and Academic & Research Institutes) and Region (Americas, Europe, Asia Pacific and Middle East & Africa) – Forecast till 2023

Market Overview

The global Dental Radiology And Dental Imaging Devices Market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 7.2%, surpassing a valuation of USD 6,503.0 million during the forecast period (2014-2023).Dental radiology and imaging devices are generally used to diagnose and treat dental problems with the help of radioactive substances, x-rays, and other forms of radiant energy.

Dental imaging systems are used to get the entire visual image of the oral cavity. There are several dental problems identified in people of all age groups, which can be detected with the help of these systems. This further helps to reduce the damage caused by the disease. Cameras are equipped in these devices, which reaches the internal corners of the oral cavity and screen in order to get the visual image of the same.

The surging use of dental imaging and radiology in orthodontic diagnosis and treatment planning is creating huge opportunities for the market to evolve. Orthodontics dental imaging and radiology is highly recommended in cases where conventional radiology is not able to supply satisfactory diagnostic information like assessing unerupted tooth position, cleft palate patients, identifying root resorption, supernumerary teeth, and planning orthognathic surgery.

Technological advancements made in the dental equipment, rising geriatric population, increased adoption of digital dental radiology and imaging systems, and rising incidences of dental surgeries are some of the primary growth stimulants of the market.
On the contrary, the dearth of reimbursement policies in dental care and the high price of digital radiology systems are some of the major concerns likely to restrict the market growth in the foreseeable future.

Global Dental Radiology and Dental Imaging Devices Market: Segmental Analysis

The dental radiology and dental imaging devices market has been segmented on the basis of device, method, imaging types, application, and end user.By method, the dental radiology and dental imaging device market is segmented into extra-oral, intra-oral, imaging, and others.The devices segment of the market comprises dental imaging and dental radiology. Of these, the dental imaging segment is predicted to command the largest market share of 29.6%.By application, the market is segregated into therapeutic, diagnosis, forensic, cosmetic, and others. Of these, the cosmetic segment is likely to acquire a major share of the global market due to the surging demand for orthodontics and dental implants in developed as well as in emerging nations.The imaging types comprises 2-dimensional (2D) and 3-dimensional (3D). Of these, the 3D imaging type is preferred by the professionals as it is technologically advanced and helps to get the entire 3D view of the oral cavity. This further helps them to get a clear understanding of the anatomy compared to 2D imaging systems.Considering the end user segment, the market is segmented into forensic laboratories, hospitals & dental clinics, and academic & research institutes. Of these, hospitals and dental clinics are anticipated to gain prominence due to favorable reimbursement policies and the availability of advanced technologies.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/674

Regional Frontiers

Geographically, the dental radiology and dental imaging devices market spans across Europe, America, Asia Pacific, and the Middle East & Africa.

Considering the global scenario, America commanded the largest market share of 39.2% in 2016 and is likely to retain its position in the foreseeable future. In this region, North America acquired the largest share, with a valuation of USD 2,118.5 million in 2023.

Professionals and researchers in this region are extensively adopting dental imaging and radiology techniques, which is predicted to contribute to the market growth in the coming years. The executive committee of the American Academy of Oral and Maxillofacial Radiology, for instance, initiated assembling position papers and guidelines for the use in radiology and dental imaging in orthodontics, endodontics, and implant planning. Improved healthcare infrastructure, surging demand for dental care, high disposable income, and rising dental problems are some of the key factors encouraging the market growth.

Europe will acquire the second spot in the global market, with Germany accounted to hold the largest share and likely to surpass a valuation of USD 376.9 million by the end of 2023. The surging practices using dental radiology and dental imaging devices is on the rise, which is benefiting the regional market’s growth.

Meanwhile, the Asia Pacific will emerge as the fastest growing market in dental radiology and dental imaging devices, with Japan holding the largest share of 26.8%. Surging awareness regarding oral care, rising dental diseases, an increasing number of dental implants, and rising disposable income are contributing to the market growth.

Industry Updates

August 2019: The KaVo ORTHOPANTOMOGRAPH OP 3D upgradeable panoramic integrated with cephalometric imaging is one of the latest configurations, which will be launched in the KaVo OP 3D family. It has been specifically designed for all dental imaging purposes and is a complete X-ray platform offering easy-to-use features across the dental imaging workflow

.Ask for Enquiry: https://www.marketresearchfuture.com/enquiry/674

Competitive Dashboard

The top players operating in the dental radiology and dental imaging devices market include Dentsply Sirona (US), Carestream Health (New York), 3M (US), KaVo Dental GmbH (Germany), Flow Dental (US), Midmark Corp. (US), LED Medical Diagnostics Inc. (Canada), and Nobel Biocare (Switzerland).

Related Report: Oral Anticoagulants Market Research Report - Global Forecast till 2023 - https://www.marketresearchfuture.com/infographics/oral-anticoagulants-market 

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.

Articaine Hydrochloride Market: Outlook Continues to Remain Positive by 2017 – 2025

Articaine Hydrochloride Market Research Report: Information, by Application (Infiltration, Nerve Block and others), End User (Dental Clinics, Hospitals and Academics & Research Institutes) and Region (Europe, North America, Asia-Pacific and the Middle East & Africa) – Forecast till 2025

Overview

The Global Articaine Hydrochloride Marketi s expected to register 8.5% CAGR and is anticipated to reach USD 1,889.0 million by 2025.

Articaine is a form of a local amide anesthetic that is most commonly used in dentistry. The articaine is marketed as a colorless liquid in vials/cartridges (2ml in each vial/cartridge). It is available in two variants, i.e., Articaine-100 & Articaine-200. Articaine-200 is more potent than Articaine-100. The dosage can be based on the type and extent of surgical procedure, depth of anesthesia, degree of muscular relaxation, and condition of the patient. For pediatric patients, dosage based on their age, weight, the physical condition of the patient, and the extent of the surgical procedure. The articaine hydrochloride industry is growing rapidly. Articaine, with its greater ability to diffuse through tissues, become a very widely used local anesthetic in the European and Canadian markets.

Market Dynamics

Articaine hydrochloride is the most popular local anesthetic for dentistry. For example, in Germany, around 97% of the anesthetic used by dentists is articaine hydrochloride. The growth of the market is likely to be driven by increasing incidences of dental caries and other periodontal diseases, advancement in dental anesthesia delivery system device, increasing the use of articaine for dental surgery, innovative nature of the dental anesthetics industry, and vigorous research and development efforts. Periodontal disease is one of the major dental diseases that influence human populations worldwide at high prevalence rates. Periodontal diseases are more prevalent in Asia-Pacific. Lack of the most basic oral health education and limited availability of simple interventions like pain relief and emergency care for acute infection and trauma to the vast majority of the population, especially in the rural areas are major reasons for the high incidences of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia-Pacific, including countries such as India, Bangladesh, Nepal, Malaysia, and Indonesia, suffer from dental decay. Furthermore, 40–59% of the population in China and Australia suffer from dental caries.Some of the popular local anesthesia other than articaine are prilocaine, lidocaine, mepivacaine, and bupivacaine. The availability and usage of alternative products are likely to thwart the growth of the articaine hydrochloride market during the forecast period.

Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/2542

Segmentation

The global articaine hydrochloride market has been segmented into application and end user. Based on application, the global market has been segmented into infiltration, nerve block, and others. Based on end-user, the global market has been segmented into dental clinics, hospitals, and academics & research institutes. The dental clinics segment accounted for a market value of USD 798.5 million in 2018.

Key Players The prominent players in the global articaine hydrochloride market are 3M (US), Anhui BBCA Pharmaceutical Co., Ltd. (China), Dentsply Sirona (US), Inibsa Dental S.L.U (Spain), Jinan Chenghui Shuangda Chemical Co., Ltd. (China), Jinan Ruixing Pharmaceutical Technology Co., Ltd (China), Manus Aktteva Biopharma LLP (India), Pfizer Inc. (US), Pierrel S.p.A (Italy), Sanofi (France), Septodont (France), Siegfried AG (Switzerland), and Sigma Aldrich (US).

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and Wherever Required We Will be Considering Covid19 Footprints for a Better Analysis of Markets and Industries. Cordially Get in Touch for More Details.